PharmaCircle Blog Xtampza ER - Competition for OxyContin

(From the PharmaCircle Drug Delivery and Formulation Newsletter, 2016-05-02). The FDA's approval last week of Collegium's extended release capsule formulation of oxycodone, Xtampza ER, represents the first serious challenge to market leader Purdue's OxyContin. Not only does Xtampza ER match up with OxyContin in terms of product features, it also received the FDA's much coveted abuse [...]